Mode
Text Size
Log in / Sign up
N/A N=50 Randomized Single-blind Other

Teaching Use of Respiratory Inhalers (TURI)

Asthma · COPD

Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Number of Participants Misusing Metered-Dose Inhaler (MDI) Post Education Between Teach to Goal (TTG) and Brief Intervention (BI) — 3; 12 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Brief Intervention (Other); Teach-to-Goal Education (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Chicago
Primary completion
Mar 2010

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Misusing Metered-Dose Inhaler (MDI) Post Education Between Teach to Goal (TTG) and Brief Intervention (BI)
3; 12
SECONDARY
Number of Participants Misusing Diskus Post Education Between TTG and BI
2; 8
SECONDARY
Number of Participants Reporting Acute Health-related Events 30 Days Post Hospital Discharge Between TTG and BI
1; 8
SECONDARY
Differences in the Prevalence of Reported Acute Health-related Events 90 Days Post Hospital Discharge Between TTG and BI
SECONDARY
Self-reported Confidence With Inhaler Technique Versus Actual Technique
6; 5

Summary

The purpose of this study is to evaluate the feasibility of enrolling and randomizing patients into one of two educational interventions to teach appropriate respiratory inhaler technique and to collect preliminary estimates of the comparative effectiveness of two types of education. Teach-to-Goal (TTG) education employs instruction followed by patient "teach-back," then repeated cycles of learning and assessment until a skill, i.e. respiratory inhaler technique, is mastered. By contrast, Brief Intervention (BI) education only consists of providing the patient with verbal and written instruction on the skill, i.e., respiratory inhaler technique. The investigators hypothesize that hospital-based TTG compared to BI increases a patient's ability to learn respiratory inhaler technique. The investigators will test this hypothesis separately for the MDI and Diskus® devices.

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • Admission to the inpatient medical service and surgical service
  • Physician-diagnosed asthma or COPD
  • Physician plans to discharge patients home on a metered dose inhaler (MDI; e.g., albuterol)

Exclusion Criteria

  • Currently in an intensive care unit
  • Physician declines to provide consent
  • Patient unable to provide assent (history of cognitive impairment, unable to understand English), or declines to provide consent
  • Previous participant in this study
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01456494). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search